Cancer vaccine, immunotherapy, oncology, tumor microenvironment
Abstract
mwymwAbstract:Due to the accumulation of DNA damage over time, an increased human lifespan leads to higher cancer incidence and mortality rates, leading to the need for more effective prevention and treatment strategies. Cancer vaccines are emerging as an innovative and promising type of immunotherapy, offering the potential for personalized, less toxic treatments that enhance long-term immune surveillance and response. This review delves into the cutting-edge progress of cancer vaccine development, emphasizing their unique ability to empower the immune system to detect and destroy cancer. Despite significant progress, the development of these vaccines faces daunting challenges related to tumor diversity, immune suppression and evasion, and the complexity of vaccine production. The use of new technologies, including artificial intelligence and genomics, may be the key to overcoming these barriers. This paper explores how innovation is pushing the boundaries of what’s possible in the fight against this unforgiving disease. The future of cancer therapy may just lie in a shot of hope.
